Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma

Published:2015 Issue: Volume:21 Page:2110-2115
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Chen Fei¹,Fan Chuming²,Gu Xuezhong³,Zhang Haixi³,Liu Qian³,Gao Xiaoli³,Lu Jie³,He Baoli⁴,Lai Xun³

Affiliation:

1. Department of Nephrology, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China (mainland)

2. Intensive Care Unit, Hospital of Yunnan Province, Kunming, Yunnan, China (mainland)

3. Department of Hematology, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China (mainland)

4. Animal Laboratory, Kunming Medical University, Kunming, Yunnan, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments;Journal of Translational Medicine;2023-07-07

2. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer;Biomedicine & Pharmacotherapy;2023-06

3. The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era;Cells;2021-06-15

4. Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects;Immunotherapy;2020-09

5. Potential strategies against resistance to CAR T-cell therapy in haematological malignancies;Therapeutic Advances in Medical Oncology;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3